MUSIi012-A-9

LATS1/2 KD

The cell line is not validated yet.

General

Cell Line

hPSCreg name MUSIi012-A-9
Cite as:
MUSIi012-A-9
Alternative name(s)
LATS1/2 KD
Cell line type Human induced pluripotent stem cell (hiPSC)
Similar lines No similar lines found.
Last update 25th May 2026
User feedback
No feedback available yet.

Login to share your feedback, experiences or results with the research community.

Provider

Generator Faculty of Medicine Siriraj Hospital (MUSI)
Owner Siriraj Center of Excellence for stem cell research
Distributors
Derivation country Thailand

External Databases

BioSamples SAMEA122709837

General Information

* Is the cell line readily obtainable for third parties?
Yes
Research use: allowed
Clinical use: allowed
Commercial use: not allowed
Subclone of

Genetic Modification

Disease/phenotype related modifications
Synonyms
  • malignant neoplasm
  • malignant tumor
  • primary cancer
Genetic modifications
LATS2 – large tumor suppressor kinase 2 (target)
Gene knock-out
LATS1 – large tumor suppressor kinase 1 (target)
Gene knock-out
CRISPR-associated (CRISPR/Cas) System

Donor Information

General Donor Information

Sex female
Ethnicity Thai

Phenotype and Disease related information (Donor)

Diseases No disease was diagnosed.

Other Genotyping (Donor)

Is there genome-wide genotyping or functional data available?
No

External Databases (Donor)

BioSamples SAMEA6013991

Ethics

Also have a look at the ethics information for the parental line MUSIi012-A .
Is there an MTA available for the cell line? No
For generation of the cell line, who was the supplier of any recombined DNA vectors or commercial kits used?
Are you aware of any constraints on the use or distribution of the cell line from the owner or any parties identified in the query above? No

hIPSC Derivation

General

The source cell information can be found in the parental cell line MUSIi012-A.

Reprogramming method

Vector type Non-integrating
Vector Episomal
Genes
Is reprogramming vector detectable?
No
Methods used
Immunostaining, RT-PCR

Vector free reprogramming

Other

Derived under xeno-free conditions
No
Derived under GMP?
No
Available as clinical grade?
No

Culture Conditions

Surface coating Matrigel/Geltrex
Feeder cells
No
O2 Concentration 5 %
CO2 Concentration 5 %
Medium Other medium:
Base medium:
Main protein source:
Serum concentration: %
Has Rock inhibitor (Y27632) been used at passage previously with this cell line?
Yes
Has Rock inhibitor (Y27632) been used at cryo previously with this cell line?
No
Has Rock inhibitor (Y27632) been used at thaw previously with this cell line?
No

Characterisation

Analysis of Undifferentiated Cells
Marker Expressed Immunostaining RT-PCR Flow Cytometry Enzymatic Assay Expression Profiles
Morphology pictures
Figure B
Figure I, J, K for pluripotentcy marker expression (I), and spontaneous differentiation (J and K).
Differentiation Potency
Endoderm
Ont Id: UBERON_0000925
Morphology
Figure J, Alpha-fetoprotein
Mesoderm
Ont Id: UBERON_0000926
Morphology
Figure J, Alpha-SMA
Ectoderm
Ont Id: UBERON_0000924
Morphology
Figure J, Beta-tubulin

Genotyping

Karyotyping (Cell Line)

Has the cell line karyotype been analysed?
Yes
46,XX
Passage number: 10
Karyotyping method: G-Banding

Other Genotyping (Cell Line)